133 related articles for article (PubMed ID: 23829615)
21. Influence of selected HLA tissue compatibility antigens on the course and efficacy of viral hepatitis C treatment--actual knowledge position.
Łoś-Rycharska E; Szaflarska-Popławska A
Adv Med Sci; 2009; 54(1):14-9. PubMed ID: 19482730
[TBL] [Abstract][Full Text] [Related]
22. Prompt arrival of antivirals against hepatitis C for HIV patients.
Barreiro P; Vispo E
AIDS Rev; 2010; 12(4):242-3. PubMed ID: 21344779
[No Abstract] [Full Text] [Related]
23. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR
Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
[TBL] [Abstract][Full Text] [Related]
24. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
Shiraha H; Iwasaki Y; Shiratori Y
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
[No Abstract] [Full Text] [Related]
25. [HCV genotype as a predictor of response to IFN therapy in chronic hepatitis C].
Ebata M; Fukuda Y; Koyama Y; Hayakawa T; Kumada T; Nakano S
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):954-8. PubMed ID: 7563909
[No Abstract] [Full Text] [Related]
26. [Change of HCV-RNA levels in liver tissue and interferon responsiveness in patients with chronic hepatitis C].
Takeuchi M; Kaneko S; Unoura M; Kobayashi K
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):969-74. PubMed ID: 7563912
[No Abstract] [Full Text] [Related]
27. Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance use disorders.
Freedman K; Nathanson J
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):363-76. PubMed ID: 19344248
[TBL] [Abstract][Full Text] [Related]
28. [Interferon therapy for acute hepatitis C: evaluation by HCV antibody, HCV genotypes and serum RNA titer].
Toyama H; Iwabuchi S
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):521-7. PubMed ID: 7563813
[No Abstract] [Full Text] [Related]
29. [Chronic hepatitis C. A new chance with Consensus Interferon for patients with handicaps].
MMW Fortschr Med; 2002 Nov; 144(45):56-7. PubMed ID: 12534066
[No Abstract] [Full Text] [Related]
30. Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.
Cornberg M; Hadem J; Herrmann E; Schuppert F; Schmidt HH; Reiser M; Marschal O; Steffen M; Manns MP; Wedemeyer H
J Hepatol; 2006 Feb; 44(2):291-301. PubMed ID: 16360972
[TBL] [Abstract][Full Text] [Related]
31. An international survey of the diagnosis, management, and treatment of hepatitis C in patients with end-stage renal disease.
Olson MR; Grewal KS; Bingaman A; Zaki R; Stewart S; Horton J; Araya V; Ortiz J
Exp Clin Transplant; 2009 Dec; 7(4):203-13. PubMed ID: 20353368
[TBL] [Abstract][Full Text] [Related]
32. Evaluating the evidence from clinical trials in chronic hepatitis C.
Brown RS
J Viral Hepat; 2006 May; 13 Suppl 1():15-25. PubMed ID: 16630043
[TBL] [Abstract][Full Text] [Related]
33. Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial.
Salmon-Céron D; Lassalle R; Pruvost A; Benech H; Bouvier-Alias M; Payan C; Goujard C; Bonnet E; Zoulim F; Morlat P; Sogni P; Pérusat S; Tréluyer JM; Chêne G;
Clin Infect Dis; 2003 May; 36(10):1295-304. PubMed ID: 12746776
[TBL] [Abstract][Full Text] [Related]
34. Consensus panel advocates prolonged interferon treatment for chronic hepatitis C.
Am J Health Syst Pharm; 1997 May; 54(10):1140, 1145. PubMed ID: 9161619
[No Abstract] [Full Text] [Related]
35. [Antiviral therapy of hepatitis C].
Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D
Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250
[TBL] [Abstract][Full Text] [Related]
36. [Current and future applications of viral clearance kinetics in the treatment of hepatitis C].
Buti M
Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():24-9. PubMed ID: 15195531
[No Abstract] [Full Text] [Related]
37. [HCV-RNA quantity of the serum].
Sasaki Y; Hige S; Nagasaka A; Matsushima T
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):965-8. PubMed ID: 7563911
[No Abstract] [Full Text] [Related]
38. [Treatment of hepatitis C. Different modalities based on viral genotype].
Pariente A
Rev Prat; 2003 Jun; 53(11):1175-6. PubMed ID: 15185639
[No Abstract] [Full Text] [Related]
39. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same.
Herion D; Hoofnagle JH
Hepatology; 1997 Mar; 25(3):769-71. PubMed ID: 9049233
[No Abstract] [Full Text] [Related]
40. Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?
Bruno R; Fagiuoli S; Sacchi P
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):699-701. PubMed ID: 21905777
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
